Chemo Brain: New Study Reveals Hidden Impact of Cancer Treatment on the Brain

Cancer patients already face a daunting diagnosis, but many are dealt a second blow: "chemo brain," also known as "brain fog." This mix of cognitive issues affects up to three-in-four patients, causing memory problems, struggling to find words, and an inability to concentrate. The effects can last years beyond cancer treatment, and a new study offers new insights into the causes of chemo brain and its connection to the brain's lymphatic system. Researchers from Virginia Tech's Cancer Research Center developed a three-tiered modeling system to study the effects of chemotherapy drugs on the brain's lymphatic system, which helps remove waste and transport immune cells.

Key Takeaways:

• Up to three-in-four cancer patients experience "chemo brain" or "brain fog," which can cause memory problems, difficulty finding words, and an inability to concentrate.
• The effects of chemo brain can last years beyond cancer treatment.
• Researchers from Virginia Tech's Cancer Research Center developed a three-tiered modeling system to study the effects of chemotherapy drugs on the brain's lymphatic system.
• The study found that chemotherapy drugs, particularly docetaxel, can cause a shrinking of the lymphatic vessels and disrupt the transport of immune cells.
• Women are disproportionately affected by chemo brain, with 75% of breast cancer patients experiencing cognitive issues.
• The study suggests that chemo brain could result from poor lymphatic-system drainage in response to chemotherapy.
• Researchers are exploring potential treatments, including delivering proteins pharmaceutically to alleviate the problem.

Statistics:

• 75% of breast cancer patients experience cognitive issues, compared to 50% of men.
• Chemo brain affects up to three-in-four cancer patients.
• The study found that chemotherapy drugs, particularly docetaxel, caused a 25% reduction in lymphatic vessel growth in mice.